650
Participants
Start Date
December 17, 2013
Primary Completion Date
November 19, 2015
Study Completion Date
November 19, 2015
Ranibizumab 0.5mg
0.5 mg ranibizumab (intravitreal injections) prefilled syringe)
Ranibizumab 0.5mg
0.5 mg ranibizumab (intravitreal injections) prefilled syringe)
Novartis Investigative Site, Ljubljana
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Ottignies
Novartis Investigative Site, Antwerp
Novartis Investigative Site, Glostrup Municipality
Novartis Investigative Site, Bern
Novartis Investigative Site, Bern
Novartis Investigative Site, Roskilde
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Pécs
Novartis Investigative Site, Zurich
Novartis Investigative Site, Zalaegerszeg
Novartis Investigative Site, Zottegem
Novartis Investigative Site, Zagreb
Novartis Investigative Site, Seongnam-si
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Hanover
Novartis Investigative Site, Oviedo
Novartis Investigative Site, Udine
Novartis Investigative Site, Padua
Novartis Investigative Site, Göttingen
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Valladolid
Novartis Investigative Site, Münster
Novartis Investigative Site, Münster
Novartis Investigative Site, Ahaus
Novartis Investigative Site, Petah Tikva
Novartis Investigative Site, Busan
Novartis Investigative Site, Zaragoza
Novartis Investigative Site, Florence
Novartis Investigative Site, Cologne
Novartis Investigative Site, Siegburg
Novartis Investigative Site, Pisa
Novartis Investigative Site, Darmstadt
Novartis Investigative Site, Sulzbach
Novartis Investigative Site, Ludwigshafen
Novartis Investigative Site, Stuttgart
Novartis Investigative Site, Rehovot
Novartis Investigative Site, Karlsruhe
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Augsburg
Novartis Investigative Site, Nové Zámky
Novartis Investigative Site, Banská Bystrica
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Kazan'
Novartis Investigative Site, Samara
Novartis Investigative Site, Bangalore
Novartis Investigative Site, Novosibirsk
Novartis Investigative Site, Vanchiyoor
Novartis Investigative Site, Haifa
Novartis Investigative Site, Tel Aviv
Novartis Investigative Site, Santiago
Novartis Investigative Site, Jerusalem
Novartis Investigative Site, Cairo
Novartis Investigative Site, Cairo
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Chemnitz
Novartis Investigative Site, Budapest
Novartis Investigative Site, Szeged
Novartis Investigative Site, Chennai
Novartis Investigative Site, Roma
Novartis Investigative Site, Sassari
Novartis Investigative Site, Coimbra
Novartis Investigative Site, Coimbra
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Porto
Novartis Investigative Site, Vila Franca de Xira
Novartis Investigative Site, Poprad
Novartis Investigative Site, Žilina
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Sant Cugat del Vallès
Novartis Investigative Site, Ankara
Novartis Investigative Site, Ankara
Novartis Investigative Site, Uxbridge
Novartis Investigative Site, Frimley
Novartis Investigative Site, Belfast
Novartis Investigative Site, Bristol
Novartis Investigative Site, Guildford, Surrey
Novartis Investigative Site, London
Novartis Investigative Site, Manchester
Novartis Investigative Site, Sunderland
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY